Iovance Biotherapeutics, Inc. IOVA Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s asset turnover?
- Iovance Biotherapeutics, Inc. (IOVA) reported asset turnover of 0.3× in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s asset turnover changed year-over-year?
- Iovance Biotherapeutics, Inc.'s asset turnover increased by 30.3% year-over-year, from 0.2× to 0.3×.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s asset turnover?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s asset turnover has grown at a 1244.0% compound annual growth rate (CAGR), from 0× to 0.3×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.